R&D Systems™ Recombinant Human FGF acidic/FGF1 (aa 16-155) Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human FGF acidic (aa 16-155) Protein is derived from E. coli. The Recombinant Human FGF acidic (aa 16-155) Protein has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2 μm filtered solution in MOPS, Na 2 SO 4 and EDTA with BSA as a carrier protein.
• Gene ID (Entrez): 2246
• Molecular Weight (g/mol): 15.5 kDa
• Name: FGF acidic aa 16-155
• Quantity: 25 μg
• Source: E. coli-derived human FGF acidic/FGF1 protein Phe16-Asp155, with an N-terminal Met
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 3 months, ≤ -20°C under sterile conditions after reconstitution.
• Gene Alias: AFGF, alpha, alpha-ECGF, beta-ECGF, ECGF, ECGFB, ECGF-betaAcidic fibroblast growth factor, endothelial cell growth factor, beta, FGF acidic, FGF-1, FGFABeta-endothelial cell growth factor, FGF-alpha, fibroblast growth factor 1 (acidic), GLIO703, HBGF1, HBGF-1, heparin-binding growth factor 1
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 97%, by SDS-PAGE under reducing conditions and visualized by silver stain.